Mia's Feed
Medical News & Research

Waist-to-Height Ratio as a Key Predictor of Heart Failure Risk

Waist-to-Height Ratio as a Key Predictor of Heart Failure Risk

Share this article

A new study indicates that waist-to-height ratio is a strong predictor of incident heart failure, surpassing traditional measures like BMI. This metric helps identify at-risk individuals based on fat distribution around visceral organs.

2 min read

A recent study presented at Heart Failure 2025 highlights the significance of the waist-to-height ratio (WtHR) in predicting the incidence of heart failure (HF). The research emphasizes that while obesity is a known risk factor for HF, traditional measures like body mass index (BMI) have limitations, as they are influenced by factors such as sex and ethnicity and do not account for fat distribution. In contrast, WtHR provides a more accurate assessment of central adiposity, which relates to harmful fat deposits around visceral organs.

The study analyzed 1,792 participants aged 45 to 73 from the Malmö Preventive Project, including individuals with normal blood glucose, impaired fasting glucose, and diabetes. Over a median follow-up of 12.6 years, 132 participants developed HF. Results showed that higher WtHR was significantly associated with increased HF risk; specifically, each standard deviation increase in WtHR raised the hazard ratio by 1.34. Participants in the highest WtHR quartile (median 0.65) had a 2.71 times greater risk of developing HF compared to those in lower quartiles.

Dr. Amra Jujic from Lund University explained that a WtHR below 0.5 is considered ideal, as waist measurements less than half of height are linked with reduced cardiometabolic risk. The findings suggest that WtHR could serve as a more effective metric than BMI for identifying patients at risk of HF who might benefit from targeted obesity therapies.

The study underscores the importance of using body composition metrics that reflect fat distribution rather than overall weight alone. Future research aims to explore WtHR's predictive power for other cardiometabolic disorders across larger populations.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Prozac Enhances Brain Plasticity by Modulating Energy Systems in Key Neurons

New research shows that Prozac promotes brain plasticity by altering energy management in key neurons, potentially improving depression treatment outcomes.

New Immunotherapy Approved in England for Severe Birch Pollen Allergies in Hay Fever Patients

A new immunotherapy treatment for severe birch pollen allergies has been approved in England, offering hope for better management of hay fever symptoms by training the immune system to build tolerance.

Deciding When to Take a Day Off for a Cold: A Guide to Managing Mild Illness

Learn how to assess if your mild cold symptoms warrant taking a day off work, prevent spreading illness, and support healthier workplace policies.

New Hope for Pulmonary Fibrosis: Nerandomilast Shows Promise in Clinical Trials

New clinical trial results reveal that nerandomilast significantly slows the progression of pulmonary fibrosis, offering hope and new treatment options for patients with this serious lung disease.